Correlation of serum IL-6, IL-8 and IL-10 levels with clinicopathological features and prognosis in patients with diffuse large B-cell lymphoma

June 2008
Croatian Medical Journal;2008, Vol. 49 Issue 3, p451
Academic Journal
No abstract available.


Related Articles

  • Effect of interleukin 21 and its receptor on CD8+ T cells in the pathogenesis of diffuse large B-cell lymphoma. ZHANSHAN CHA; HAIHUI GU; HUIJUN GUO; XIAOHUA TU; YAN ZANG; CHUNYAN ZHAO; MEIXIAN HUA; RECHLIC, JAMES R.; OLASNOVA, LINDSAY M.; HAIHAN SONG; BAOHUA QIAN // Oncology Letters;2014, Vol. 8 Issue 1, p421 

    Interleukin 21 (IL-21) and its receptor, IL-21R, play a key role in innate and adaptive immunity. In the present study, the effect of IL-21 and IL-21R on the pathogenesis of diffuse large B-cell lymphoma (DLBCL) was investigated. The serum levels of IL-21 were detected by enzyme-linked...

  • Serum level of soluble interleukin-2 receptor correlates with CD25 expression in patients with T lymphoblastic lymphoma. Toji, Tomohiro; Takata, Katsuyoshi; Sato, Yasuharu; Miyata-Takata, Tomoko; Hayashi, Eiko; Habara, Toshiyuki; Maeda, Yoshinobu; Tanimoto, Mitsune; Yoshino, Tadashi // Journal of Clinical Pathology;Aug2015, Vol. 68 Issue 8, p622 

    Acute lymphoblastic leukaemia/lymphoma (ALL/LBL) is an aggressive form of non-Hodgkin's lymphoma (NHL) affecting B-cells or T-cells, respectively. The serum level of soluble interleukin-2 receptor (sIL-2R) is known to reflect the immune activity and tumour volume in aggressive NHL; however, the...

  • Favorable impact of the interleukin-4 receptor allelic variant I75 on the survival of diffuse large B-cell lymphoma patients demonstrated in a large prospective clinical trial. Schoof, N.; Von Bonin, F.; Zeynalova, S.; Ziepert, M.; Jung, W.; Loeffler, M.; Pfreundschuh, M.; Trümper, L.; Kube, D. // Annals of Oncology;Sep2009, Vol. 20 Issue 9, p1548 

    Background: Recently published data indicate that host germline variations in immune genes can influence the outcome of lymphoma patients. Interleukin (IL)-4 and IL13 are crucial immune factors and may influence the course of the disease. Both cytokines signal through the interleukin-4 receptor...

  • Serum interleukin-6 and -10 levels in patients with gastric cancer. Ikeguchi, Masahide; Hatada, Tomoko; Yamamoto, Manabu; Miyake, Takanori; Matsunaga, Tomonori; Fukumoto, Youji; Yamada, Yoshinori; Fukuda, Kenji; Saito, Hiroaki; Tatebe, Shigeru // Gastric Cancer;Jun2009, Vol. 12 Issue 2, p95 

    Interleukin-6 (IL-6) is known to be a multifunctional cytokine and IL-10 is an immunosuppressive factor. Both have been reported to be related to the disease prognosis in some human solid tumors. In the present study, we evaluated the clinical significance of preoperative serum IL-6 and IL-10...

  • Serum interleukin-33 levels in patients with gastric cancer. Sun, Pinghu; Ben, Qiwen; Tu, Shuiping; Dong, Wenjie; Qi, Xiaoguang; Wu, Yunlin // Digestive Diseases & Sciences;Dec2011, Vol. 56 Issue 12, p3596 

    Background: Interleukin-33 (IL-33) is a novel member of the IL-1 family of cytokines, and it is closely related to IL-18, one of the best characterized members of the IL-1 family. It's been demonstrated that elevated levels of IL-18 are involved in a wide variety of tumors,...

  • Serum levels of IL-6 and TNF-acorrelate with clinicopathological features and patient survival in patients with prostate cancer. Michalaki, V.; Syrigos, K.; Charles, P.; Waxman, J. // British Journal of Cancer;9/13/2004, Vol. 91 Issue 6, p1227 

    Presents a correction to the article "Serum Levels of IL-6 and TNF-&b.alpha Correlate With Clinicopathological Features and Patient Survival in Patients with Prostate Cancer" that was previously published in "British Journal of Cancer."

  • Clinical Significance of sIL-2R Levels in B-Cell Lymphomas. Yoshida, Noriaki; Oda, Miyo; Kuroda, Yoshiaki; Katayama, Yuta; Okikawa, Yoshiko; Masunari, Taro; Fujiwara, Megumu; Nishisaka, Takashi; Sasaki, Naomi; Sadahira, Yoshito; Mihara, Keichiro; Asaoku, Hideki; Matsui, Hirotaka; Seto, Masao; Kimura, Akiro; Arihiro, Koji; Sakai, Akira // PLoS ONE;Nov2013, Vol. 8 Issue 11, p1 

    Elevated soluble interleukin-2 receptor (sIL-2R) in sera is observed in patients with malignant lymphoma (ML). Therefore, sIL-2R is commonly used as a diagnostic and prognostic marker for ML, but the mechanisms responsible for the increase in sIL-2R levels in patients with B-cell lymphomas have...

  • STAT3 activation is associated with cerebrospinal fluid interleukin-10 (IL-10) in primary central nervous system diffuse large B cell lymphoma. Mizowaki, Takashi; Sasayama, Takashi; Tanaka, Kazuhiro; Mizukawa, Katsu; Takata, Kumi; Nakamizo, Satoshi; Tanaka, Hirotomo; Nagashima, Hiroaki; Nishihara, Masamitsu; Hirose, Takanori; Itoh, Tomoo; Kohmura, Eiji // Journal of Neuro-Oncology;Sep2015, Vol. 124 Issue 2, p165 

    Signal transducers and activators of transcription 3 (STAT3) are activated by various cytokines and oncogenes; however, the activity and pathogenesis of STAT3 in diffuse large B cell lymphoma of the central nervous system have not been thoroughly elucidated. We investigated the phosphorylation...

  • Functional Interleukin-21 Polymorphism Is a Protective Factor of Diffuse Large B-Cell Lymphoma. Wang, Hui; Wang, Mingjun; Feng, Zhenjun; Chen, Lei; Gao, Lei; Li, Qiang; Zhang, Li; Ma, Junjie // DNA & Cell Biology;Nov2014, Vol. 33 Issue 11, p775 

    Interleukin-21 (IL-21) is a recently discovered cytokine and plays critical roles in antitumor immune responses. Diffuse large B-cell lymphoma (DLBCL) is the most common type of non-Hodgkin lymphoma. In this study, we investigated the association between IL-21 genetic polymorphisms and the...

  • Interleukin-23A is associated with tumor growth in Helicobacter-pylori-related human gastric cancer. Changming Liu; Ying Zhang; Jie Zhan; Yuanyuan Zhao; Qijun Wan; Huiping Peng; Wei Zhu // Cancer Cell International;2014, Vol. 14 Issue 1, p1 

    Background Interleukin (IL)-23 is one of the newly identified inflammatory cytokines, and inflammation is also known to be related to the development of gastric cancer (GC). The role of IL-23 in gastric cancer, however, is largely unknown. In the present study, we investigated the expression and...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics